Fig. 3

PSA promoter-driven CRISPR-dCas9-KRAB inhibits the proliferation and migration of prostate cancer cells. A MTT experiment results found that PSA-dCas9-KRAB significantly inhibited the viability of prostate cancer cells. B Cell scratch experiment results found that PSA-dCas9-KRAB significantly inhibited the migration rate of prostate cancer cells. **P < 0.01 (Student’s t-test, n = 3 replicates)